Mondelez International, Inc.
NASDAQ:MDLZFood Confectioners
-$0.66 today
- Market cap
- $84.26B
- Beta
- 0.40
- P/E (TTM)
- 29.8
- EPS (TTM)
- $2.02
- Dividend yield
- 3.27%
Volume 9.37M
Average 8.33M
MDLZ EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Mondelez International, Inc.NASDAQ: MDLZ
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $2.39B rose 77.9% year over year, ahead of the +4.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 89.0% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.
Context
- EBITDA amounted to 12.9% of revenue in FY2025, down 9.2 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 15 analysts of $6.53B (+31.4%) for the fiscal year ending Dec 2026, a step up from the -38.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $2.39B+89.0% QoQ
- Last fiscal yearDec 2025
- $4.97B-38.4% YoY
- LTMJun 2026
- $6.26B+4.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +77.9% | +31.3% | -46.6 pp |
| 1 year | -38.4% | +31.4% | +69.8 pp |
| 3-year CAGR | +1.4% | +14.9% | +13.5 pp |
| 5-year CAGR | +11.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 4.97B USD
- Year-over-year change
- -38.4%
- 4-year CAGR
- -4.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.97B | -38.4% |
| FY2024 | 2024-12-31 | 8.07B | +5.6% |
| FY2023 | 2023-12-31 | 7.65B | +60.5% |
| FY2022 | 2022-12-31 | 4.76B | -18.5% |
| FY2021 | 2021-12-31 | 5.85B | — |
EBITDA vs competitors
How MDLZ compares with its peers on the latest reported figures
- MDLZ's LTM Jun 2026 EBITDA of $6.26B is the highest of the 3 companies compared; the peer median is $1.37B.
- Its year-over-year change of +4.1% is the 2nd highest of 3, against a peer median of -8.9%.
- EBITDA amounts to 15.8% of revenue for MDLZ, versus a peer median of 19.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.26B | +4.1% | +1.4% | 15.8% | |
| LTM Jun 2026 | $2.61B | +9.3% | -7.1% | 21.5% | |
| LTM Sep 2026 | $132.42M | -27.2% | +10.6% | 18.1% | |
| Peer median (excluding MDLZ) | $1.37B | -8.9% | +1.7% | 19.8% | |
Competitors are the stored peer set for MDLZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 28.72B | 31.5B | 36.02B | 36.44B | 38.54B |
| Cost of Revenue | 17.47B | 20.18B | 22.25B | 22.18B | 27.6B |
| Gross Profit | 11.25B | 11.31B | 13.76B | 14.26B | 10.94B |
| Gross Margin | 39.2% | 35.9% | 38.2% | 39.1% | 28.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.26B | 7.38B | 8B | 7.44B | 7.17B |
| Operating Expenses | 6.6B | 7.78B | 8.26B | 7.91B | 7.39B |
| Depreciation & Amortization | 1.11B | 1.11B | 1.22B | 1.3B | 1.36B |
| EBITDA | 5.85B | 4.76B | 7.65B | 8.07B | 4.97B |
| EBITDA Margin | 20.4% | 15.1% | 21.2% | 22.1% | 12.9% |
| Operating Income | 4.65B | 3.53B | 5.5B | 6.35B | 3.55B |
| Operating Margin | 16.2% | 11.2% | 15.3% | 17.4% | 9.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 365M | 428M | 550M | 508M | 599M |
| Other Income / Expenses | (284M) | (306M) | 378M | (84M) | (534M) |
| Income Before Tax | 4.37B | 3.23B | 5.88B | 6.26B | 3.01B |
| Pre-Tax Margin | 15.2% | 10.2% | 16.3% | 17.2% | 7.8% |
| Income Tax Expense | 1.19B | 865M | 1.54B | 1.47B | 782M |
| Net Income | 4.3B | 2.72B | 4.96B | 4.61B | 2.45B |
| Net Margin | 15.0% | 8.6% | 13.8% | 12.7% | 6.4% |
| EPS (Basic) | 3.06 | 1.97 | 3.64 | 3.44 | 1.89 |
| EPS (Diluted) | 3.04 | 1.96 | 3.62 | 3.42 | 1.89 |
| Weighted Avg Shares | 1.4B | 1.38B | 1.36B | 1.34B | 1.29B |
| Weighted Avg Shares (Diluted) | 1.41B | 1.39B | 1.37B | 1.35B | 1.3B |
Mondelez International, Inc.
NASDAQ:MDLZ
Intrinsic Alpha fair value
Locked
Current Price
$66.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.